Cargando…
Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
The corneal endothelium maintains corneal transparency; consequently, its dysfunction causes severe vision loss. Tissue engineering-based therapy, as an alternative to conventional donor corneal transplantation, is anticipated to provide a less invasive and more effective therapeutic modality. We co...
Autores principales: | Okumura, Naoki, Sakamoto, Yuji, Fujii, Keita, Kitano, Junji, Nakano, Shinichiro, Tsujimoto, Yuki, Nakamura, Shin-ichiro, Ueno, Morio, Hagiya, Michio, Hamuro, Junji, Matsuyama, Akifumi, Suzuki, Shingo, Shiina, Takashi, Kinoshita, Shigeru, Koizumi, Noriko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870691/ https://www.ncbi.nlm.nih.gov/pubmed/27189516 http://dx.doi.org/10.1038/srep26113 |
Ejemplares similares
-
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
por: Okumura, Naoki, et al.
Publicado: (2017) -
Inhibition of TGF-β Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine
por: Okumura, Naoki, et al.
Publicado: (2013) -
A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma
por: Yamamoto, Mayumi, et al.
Publicado: (2012) -
Metabolites Interrogation in Cell Fate Decision of Cultured Human Corneal Endothelial Cells
por: Hamuro, Junji, et al.
Publicado: (2020) -
Mitochondria as a Platform for Dictating the Cell Fate of Cultured Human Corneal Endothelial Cells
por: Numa, Kohsaku, et al.
Publicado: (2020)